About Technology Issues FAQ

Links

Official Page

Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study

Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.